Titan Pharmaceuticals Inc (TTNP)

[Rentier]

When swallowed intact, however, Embeda can still be abused or misused because the naltrexone is not expected to substantially block the euphoric effects of the morphine. It is unknown whether the abuse-deterrent properties of Embeda will result in a reduction in abuse by the intravenous route until additional postmarketing data are available.

Ok, then what is point? I'll tell you they did this to get patent protection extension for Embeda. Change the formulation slightly (oh now it's ER edition) and you now get years more added to your patent and no generics can be made.

So, basically if you are an addict and want get high with Embeda don't bother crushing them just take them whole...

Then we have this:

Embeda is not approved, and should not be used, for as-needed pain relief.

Yeah, right idiots at FDA who do you think most the scrips will be written for?! So, they can't sell/market it as such since you the FDA says it isn't approved for that off-label use, as if that is going to stop Dr. from writing for it.